アネキシンV
“Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population”. Annals of the New York Academy of Sciences 1108 (1): 96–103. (Jun 2007). doi:10.1196/annals.1422.011. PMID 17893975.
“Inhibition of protein kinase C by annexin V”. Biochemistry 31 (6): 1886–91. (Feb 1992). doi:10.1021/bi00121a043. PMID 1310621.
“Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins”. Journal of Molecular Biology 223 (3): 683–704. (Feb 1992). doi:10.1016/0022-2836(92)90984-R. PMID 1311770.
“The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes”. The EMBO Journal 9 (12): 3867–74. (Dec 1990). doi:10.1002/j.1460-2075.1990.tb07605.x. PMC 552154. PMID 2147412. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC552154/.
“The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution. Implications for membrane binding and calcium channel activity”. FEBS Letters 275 (1–2): 15–21. (Nov 1990). doi:10.1016/0014-5793(90)81428-Q. PMID 2148156.
“Cloning and expression of cDNA for human vascular anticoagulant, a Ca2+-dependent phospholipid-binding protein”. European Journal of Biochemistry 174 (4): 585–92.